These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7070554)

  • 1. Potential anticancer agents. XXIII. 1. Qualitative structure--activity relationship in the "classical" antifolates area.
    Niculescu-Duvaz I; Ciustea G; Stoicescu D; Muresan Z; Dobre V
    Neoplasma; 1982; 29(1):43-52. PubMed ID: 7070554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
    Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
    J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
    Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
    J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential anticancer agents. XXIII. 2. Quantitative structure--activity relationships (QSAR) in the "classical" antifolates area.
    Niculescu-Duvaz I; Craescu T
    Neoplasma; 1982; 29(1):53-63. PubMed ID: 7070555
    [No Abstract]   [Full Text] [Related]  

  • 5. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate analogues. 33. N delta-acyl-N alpha-(4-amino-4-deoxypteroyl)-L-ornithine derivatives: synthesis and in vitro antitumor activity.
    Rosowsky A; Bader H; Cucchi CA; Moran RG; Kohler W; Freisheim JH
    J Med Chem; 1988 Jul; 31(7):1332-7. PubMed ID: 3385730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate analogues. 31. Meta and ortho isomers of aminopterin, compounds with a double bond in the side chain, and a novel analogue modified at the alpha-carbon: chemical and in vitro biological studies.
    Rosowsky A; Bader H; Forsch RA; Moran RG; Freisheim JH
    J Med Chem; 1988 Apr; 31(4):763-8. PubMed ID: 3351853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential anticancer agents. 16. Methotrexate analogues with a modified peptide side chain.
    Suster DC; Tărnăuceanu E; Ionescu D; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1978 Nov; 21(11):1162-5. PubMed ID: 722722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
    Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
    J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on analogues of classical antifolates bearing the naphthoyl group in place of benzoyl in the side chain.
    Piper JR; Johnson CA; Maddry JA; Malik ND; McGuire JJ; Otter GM; Sirotnak FM
    J Med Chem; 1993 Dec; 36(26):4161-71. PubMed ID: 8277497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Chen G; Wright JE; Rosowsky A
    Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate analogues. 19. Replacement of the glutamate side chain in classical antifolates by L-homocysteic acid and L-cysteic acid: effect on enzyme inhibition and antitumor activity.
    Rosowsky A; Forsch RA; Freisheim JH; Moran RG; Wick M
    J Med Chem; 1984 May; 27(5):600-4. PubMed ID: 6546949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential anticancer agents. 17. Analogues of methotrexate with a tripeptide side chain.
    Suster DC; Tărnăuceanu E; Botez G; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1978 Nov; 21(11):1165-7. PubMed ID: 722723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate analogues. 28. Synthesis and biological evaluation of new gamma-monoamides of aminopterin and methotrexate.
    Rosowsky A; Bader H; Radike-Smith M; Cucchi CA; Wick MM; Freisheim JH
    J Med Chem; 1986 Sep; 29(9):1703-9. PubMed ID: 3462394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization.
    McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H
    Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
    J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues.
    Rosowsky A; Forsch RA; Wright JE
    J Med Chem; 2004 Dec; 47(27):6958-63. PubMed ID: 15615544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines.
    Gangjee A; Adair O; Queener SF
    J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
    Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ
    J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of classical and nonclassical, partially restricted, linear, tricyclic 5-deaza antifolates.
    Gangjee A; Zeng Y; McGuire JJ; Kisliuk RL
    J Med Chem; 2002 Nov; 45(23):5173-81. PubMed ID: 12408727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.